Actinium Pharmaceuticals Statistics
Total Valuation
ATNM has a market cap or net worth of $38.37 million. The enterprise value is -$14.19 million.
Important Dates
The last earnings date was Friday, November 14, 2025, after market close.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ATNM has 31.20 million shares outstanding. The number of shares has increased by 7.11% in one year.
| Current Share Class | 31.20M |
| Shares Outstanding | 31.20M |
| Shares Change (YoY) | +7.11% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.08% |
| Owned by Institutions (%) | 19.84% |
| Float | 30.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 422.88 |
| Forward PS | n/a |
| PB Ratio | 2.76 |
| P/TBV Ratio | 2.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.96, with a Debt / Equity ratio of 0.08.
| Current Ratio | 7.96 |
| Quick Ratio | 7.81 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -133.09% and return on invested capital (ROIC) is -85.10%.
| Return on Equity (ROE) | -133.09% |
| Return on Assets (ROA) | -33.76% |
| Return on Invested Capital (ROIC) | -85.10% |
| Return on Capital Employed (ROCE) | -75.71% |
| Weighted Average Cost of Capital (WACC) | 2.53% |
| Revenue Per Employee | $3,600 |
| Profits Per Employee | -$1.38M |
| Employee Count | 25 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.43% in the last 52 weeks. The beta is -0.30, so ATNM's price volatility has been lower than the market average.
| Beta (5Y) | -0.30 |
| 52-Week Price Change | -5.43% |
| 50-Day Moving Average | 1.41 |
| 200-Day Moving Average | 1.52 |
| Relative Strength Index (RSI) | 36.77 |
| Average Volume (20 Days) | 128,490 |
Short Selling Information
The latest short interest is 875,498, so 2.81% of the outstanding shares have been sold short.
| Short Interest | 875,498 |
| Short Previous Month | 887,393 |
| Short % of Shares Out | 2.81% |
| Short % of Float | 2.84% |
| Short Ratio (days to cover) | 4.63 |
Income Statement
In the last 12 months, ATNM had revenue of $90,000 and -$34.60 million in losses. Loss per share was -$1.11.
| Revenue | 90,000 |
| Gross Profit | 90,000 |
| Operating Income | -37.34M |
| Pretax Income | -34.60M |
| Net Income | -34.60M |
| EBITDA | -37.12M |
| EBIT | -37.34M |
| Loss Per Share | -$1.11 |
Full Income StatementBalance Sheet
The company has $53.39 million in cash and $1.14 million in debt, with a net cash position of $52.25 million or $1.67 per share.
| Cash & Cash Equivalents | 53.39M |
| Total Debt | 1.14M |
| Net Cash | 52.25M |
| Net Cash Per Share | $1.67 |
| Equity (Book Value) | 13.78M |
| Book Value Per Share | 0.44 |
| Working Capital | 47.53M |
Full Balance SheetCash Flow
| Operating Cash Flow | -25.04M |
| Capital Expenditures | n/a |
| Free Cash Flow | -25.04M |
| FCF Per Share | -$0.80 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -41,486.67% |
| Pretax Margin | -38,443.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATNM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.11% |
| Shareholder Yield | n/a |
| Earnings Yield | -90.91% |
| FCF Yield | -65.80% |
Analyst Forecast
The average price target for ATNM is $4.00, which is 225.20% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 225.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 11, 2020. It was a reverse split with a ratio of 1:30.
| Last Split Date | Aug 11, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
ATNM has an Altman Z-Score of -10.59 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.59 |
| Piotroski F-Score | 2 |
